We are live on ! Find out more
PIM

Platinum Investment Management Portfolio holdings

AUM $397M
1-Year Est. Return 63.96%
This Fund
S&P 500
This Quarter Est. Return
+3.1%
1 Year Est. Return
+63.96%
3 Year Est. Return
+135%
5 Year Est. Return
+149.46%
10 Year Est. Return
+636.06%
AUM
$3.59B
AUM Growth
+$41.6M
Cap. Flow
+$65.7M
Cap. Flow %
1.83%
Top 10 Hldgs %
58.03%
Holding
157
New
11
Increased
42
Reduced
36
Closed
13

Top Sells

Rank Stock Value
1
LPX icon
Louisiana-Pacific
LPX
+$83.4M
2
ZTO icon
ZTO Express
ZTO
+$28.7M
3
GILD icon
Gilead Sciences
GILD
+$23.3M
4
HCC icon
Warrior Met Coal
HCC
+$18.5M
5
SWKS icon
Skyworks Solutions
SWKS
+$9.89M

Sector Composition

Rank Sector Weight
1 Technology 27.52%
2 Consumer Discretionary 17.85%
3 Industrials 16.75%
4 Healthcare 13.27%
5 Materials 10.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROIV icon
76
Roivant Sciences
ROIV
$25.9B
$3.26M 0.09%
+323,643
New +$2.69M
ADPT icon
77
Adaptive Biotechnologies
ADPT
$4.15B
$3.21M 0.09%
114,418
+32,524
+40% +$997K
ADI icon
78
Analog Devices
ADI
$188B
$3.19M 0.09%
18,145
MRSN
79
DELISTED
Mersana Therapeutics
MRSN
$3.08M 0.09%
19,819
+15,383
+347% +$2.99M
BCRX icon
80
BioCryst Pharmaceuticals
BCRX
$2.45B
$3.07M 0.09%
221,699
+92,011
+71% +$1.22M
OMIC
81
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$3.04M 0.08%
8,781
+5,207
+146% +$2.02M
MYOV
82
DELISTED
Myovant Sciences Ltd.
MYOV
$3.04M 0.08%
195,211
PRTA icon
83
Prothena Corp
PRTA
$447M
$2.99M 0.08%
60,512
BPMC
84
DELISTED
Blueprint Medicines
BPMC
$2.9M 0.08%
27,121
CLF icon
85
Cleveland-Cliffs
CLF
$7.18B
$2.82M 0.08%
129,562
-112,684
-47% -$2.43M
HOWL icon
86
Werewolf Therapeutics
HOWL
$19M
$2.54M 0.07%
213,381
WDC icon
87
Western Digital
WDC
$153B
$2.52M 0.07%
+51,049
New +$2.22M
RCUS icon
88
Arcus Biosciences
RCUS
$3.67B
$2.5M 0.07%
61,780
OCFT
89
DELISTED
OneConnect Financial Technology
OCFT
$2.47M 0.07%
100,085
OVID icon
90
Ovid Therapeutics
OVID
$476M
$2.46M 0.07%
766,901
ABSI icon
91
Absci
ABSI
$1.53B
$2.44M 0.07%
297,823
+10,263
+4% +$117K
DNLI icon
92
Denali Therapeutics
DNLI
$3.96B
$2.27M 0.06%
50,971
+20,180
+66% +$956K
CSCO icon
93
Cisco
CSCO
$490B
$2.26M 0.06%
35,700
BNTX icon
94
BioNTech
BNTX
$23.4B
$1.93M 0.05%
7,492
INFO
95
DELISTED
IHS Markit Ltd. Common Shares
INFO
$1.91M 0.05%
14,338
BCAB icon
96
BioAtla
BCAB
$5.74M
$1.79M 0.05%
1,825
+692
+61% +$885K
ORTX
97
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$1.76M 0.05%
133,517
+25,685
+24% +$425K
CVNA icon
98
Carvana
CVNA
$79.7B
$1.71M 0.05%
36,980
-4,600
-11% -$253K
SGMO
99
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$1.64M 0.05%
218,336
XLNX
100
DELISTED
Xilinx Inc
XLNX
$1.62M 0.05%
7,650
-1,559
-17% -$307K

Similar funds

Platinum Investment Management's Q4 2021 Portfolio in Review

As of Q4 2021, Platinum Investment Management held 157 positions worth $3.59B, up 1.2% from $3.55B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Platinum Investment Management's Q4 2021 filing shows 11 new, 42 increased, 36 reduced and 13 closed positions. Its largest new stake was Iris Energy: 2,717,193 shares worth $43.9M. The largest sale was Louisiana-Pacific, an estimated $83.4M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Platinum Investment Management's largest Q4 2021 buy was Iris Energy: 2,717,193 shares worth $43.9M.
  • Platinum Investment Management added most to Roblox in Q4 2021, an estimated $52M increase.
  • Platinum Investment Management's biggest Q4 2021 reduction was ZTO Express, cutting an estimated $28.7M.
  • Platinum Investment Management fully exited Louisiana-Pacific in Q4 2021, selling an estimated $83.4M.
  • Platinum Investment Management's ten largest holdings make up 58% of its $3.59B portfolio in Q4 2021.
  • Platinum Investment Management opened 11 new positions and closed 13 in Q4 2021.
  • Platinum Investment Management's portfolio value rose 1.2% quarter-over-quarter to $3.59B.

Based on Platinum Investment Management's 13F filing for Q4 2021, filed 11 Feb 2022.